Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comparison of LI-RADS 2018 and KLCA-NCC 2018 for noninvasive diagnosis of hepatocellular carcinoma using magnetic resonance imaging
Sunyoung Lee, Seung‐seob Kim, Dong Ryul Chang, et al.
Clinical and Molecular Hepatology (2020) Vol. 26, Iss. 3, pp. 340-351
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

Clinical and Molecular Hepatology (2022) Vol. 28, Iss. 4, pp. 583-705
Open Access | Times Cited: 189
2022 KLCA-NCC Korea Practice Guidelines for the Management of Hepatocellular Carcinoma

Korean Journal of Radiology (2022) Vol. 23, Iss. 12, pp. 1126-1126
Open Access | Times Cited: 88
2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

Journal of Liver Cancer (2022) Vol. 23, Iss. 1, pp. 1-120
Open Access | Times Cited: 80
Overview of Asian clinical practice guidelines for the management of hepatocellular carcinoma: An Asian perspective comparison
Yuri Cho, Bo Hyun Kim, Joong‐Won Park
Clinical and Molecular Hepatology (2023) Vol. 29, Iss. 2, pp. 252-262
Open Access | Times Cited: 39
Clinical practice guideline and real-life practice in hepatocellular carcinoma: A Korean perspective
Myung Ji Goh, Dong Hyun Sinn, Jong Man Kim, et al.
Clinical and Molecular Hepatology (2023) Vol. 29, Iss. 2, pp. 197-205
Open Access | Times Cited: 22
Predictive biomarkers of survival in patients with advanced hepatocellular carcinoma receiving atezolizumab plus bevacizumab treatment
Young Eun Chon, Jaekyung Cheon, Hyeyeong Kim, et al.
Cancer Medicine (2022) Vol. 12, Iss. 3, pp. 2731-2738
Open Access | Times Cited: 29
Sonazoid-enhanced ultrasonography: comparison with CT/MRI Liver Imaging Reporting and Data System in patients with suspected hepatocellular carcinoma
Jeong Ah Hwang, Woo Kyoung Jeong, Ji Hye Min, et al.
ULTRASONOGRAPHY (2021) Vol. 40, Iss. 4, pp. 486-498
Open Access | Times Cited: 36
Current State of Evidence for Use of MRI in LI‐RADS
Ameya Kulkarni, Danielle Kruse, Kelly C. Harper, et al.
Journal of Magnetic Resonance Imaging (2025)
Open Access
Metformin and Dichloroacetate Suppress Proliferation of Liver Cancer Cells by Inhibiting mTOR Complex 1
Tae Suk Kim, Minjong Lee, Minji Park, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 18, pp. 10027-10027
Open Access | Times Cited: 29
Comparison of Four Diagnostic Guidelines for Hepatocellular Carcinoma Using Gadoxetic Acid–enhanced Liver MRI
Jeong Hee Yoon, Young Kon Kim, Jeong Woo Kim, et al.
Radiology (2024) Vol. 311, Iss. 1
Closed Access | Times Cited: 4
Performance of LI-RADS category 5 vs combined categories 4 and 5: a systemic review and meta-analysis
Sunyoung Lee, Yeun‐Yoon Kim, Jaeseung Shin, et al.
European Radiology (2024) Vol. 34, Iss. 11, pp. 7025-7040
Closed Access | Times Cited: 4
LI‐RADS Major Features on MRI for Diagnosing Hepatocellular Carcinoma: A Systematic Review and Meta‐Analysis
Jaeseung Shin, Sunyoung Lee, Ja Kyung Yoon, et al.
Journal of Magnetic Resonance Imaging (2021) Vol. 54, Iss. 2, pp. 518-525
Closed Access | Times Cited: 25
Outcome of untreated low-level viremia versus antiviral therapy-induced or spontaneous undetectable HBV-DNA in compensated cirrhosis
Daniel Q. Huang, Nobuharu Tamaki, Hyung Woong Lee, et al.
Hepatology (2023) Vol. 77, Iss. 5, pp. 1746-1756
Closed Access | Times Cited: 10
Management Consensus Guidelines for Hepatocellular Carcinoma: 2023 Update on Surveillance, Diagnosis, Systemic Treatment, and Posttreatment Monitoring by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
Wei Teng, Hung‐Wei Wang, Shi‐Ming Lin
Liver Cancer (2024) Vol. 13, Iss. 5, pp. 468-486
Open Access | Times Cited: 3
Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis B
Hye Won Lee, Young Youn Cho, Hyein Lee, et al.
Hepatology International (2021) Vol. 15, Iss. 5, pp. 1083-1092
Open Access | Times Cited: 22
Retrospective analysis of current guidelines for hepatocellular carcinoma diagnosis on gadoxetic acid–enhanced MRI in at-risk patients
So Hyun Park, Young Sup Shim, Bohyun Kim, et al.
European Radiology (2021) Vol. 31, Iss. 7, pp. 4751-4763
Closed Access | Times Cited: 19
Effect of tenofovir alafenamide vs. tenofovir disoproxil fumarate on hepatocellular carcinoma risk in chronic hepatitis B
Hye Won Lee, Young Youn Cho, Hyein Lee, et al.
Journal of Viral Hepatitis (2021) Vol. 28, Iss. 11, pp. 1570-1578
Closed Access | Times Cited: 19
Prognosis of Primary Liver Cancer Based on LI-RADS Classification with Extracellular Agent-Enhanced MRI
Yubo Li, Xiaoyan Ni, Xinai Liu, et al.
Journal of Hepatocellular Carcinoma (2023) Vol. Volume 10, pp. 399-411
Open Access | Times Cited: 7
Should Threshold Growth Be Considered a Major Feature in the Diagnosis of Hepatocellular Carcinoma Using LI-RADS?
Jae Hyon Park, Yong Eun Chung, Nieun Seo, et al.
Korean Journal of Radiology (2021) Vol. 22, Iss. 10, pp. 1628-1628
Open Access | Times Cited: 17
Value of threshold growth as a major diagnostic feature of hepatocellular carcinoma in LI-RADS
Se Jin Choi, Sang Hyun Choi, Dong Wook Kim, et al.
Journal of Hepatology (2022) Vol. 78, Iss. 3, pp. 596-603
Closed Access | Times Cited: 11
Noninvasive risk assessment of hepatic decompensation in patients with hepatitis B virus‐related liver cirrhosis
David Sooik Kim, Beom Kyung Kim, Jae Seung Lee, et al.
Journal of Gastroenterology and Hepatology (2023) Vol. 38, Iss. 8, pp. 1372-1380
Closed Access | Times Cited: 6
Impact of the Liver Imaging Reporting and Data System on Research Studies of Diagnosing Hepatocellular Carcinoma Using MRI
Yura Ahn, Sang Hyun Choi, Jong Keon Jang, et al.
Korean Journal of Radiology (2022) Vol. 23, Iss. 5, pp. 529-529
Open Access | Times Cited: 9
Simplified LI-RADS for Hepatocellular Carcinoma Diagnosis at Gadoxetic Acid–enhanced MRI
Minha Kwag, Sang Hyun Choi, Se Jin Choi, et al.
Radiology (2022) Vol. 305, Iss. 3, pp. 614-622
Closed Access | Times Cited: 8
Prognostic Impact of MAFLD Following Surgical Resection of Hepatitis B Virus-Related Hepatocellular Carcinoma: A Nationwide Cohort Study
Byungyoon Yun, Sang Hoon Ahn, Juyeon Oh, et al.
Cancers (2022) Vol. 14, Iss. 20, pp. 5002-5002
Open Access | Times Cited: 8
Accuracy of Various Forms of Contrast-Enhanced MRI for Diagnosing Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
Chun Na Zhao, Hongyan Dai, Ju-Wei Shao, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top